To investigate the influence of IL-33 in antigen-induced airway pathology we modified a previously established mast cell-dependent asthma model, which is based on sensitization with repetitive i.p. injections of low-dose OVA without adjuvant followed by intranasal OVA challenge22. Here, IL33 is linked to asthma.